231 related articles for article (PubMed ID: 31101690)
1. Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for
Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong IC; Leung WK
Gut; 2020 Mar; 69(3):445-452. PubMed ID: 31101690
[TBL] [Abstract][Full Text] [Related]
2. Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
Guo CG; Zhang F; Wu JT; Cheung KS; Li B; Law SYK; Leung WK
United European Gastroenterol J; 2021 Jun; 9(5):543-551. PubMed ID: 33956403
[TBL] [Abstract][Full Text] [Related]
3. Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis.
Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong ICK; Leung WK
Aliment Pharmacol Ther; 2019 Nov; 50(9):1001-1008. PubMed ID: 31583734
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin.
Cea Soriano L; Lanas A; Soriano-Gabarró M; García Rodríguez LA
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):887-895.e6. PubMed ID: 29908361
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study.
Cheung KS; Chan EW; Wong AYS; Chen L; Seto WK; Wong ICK; Leung WK
J Natl Cancer Inst; 2018 Jul; 110(7):743-749. PubMed ID: 29361002
[TBL] [Abstract][Full Text] [Related]
6. Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study.
Shami JJP; Zhao J; Pathadka S; Wan EYF; Blais JE; Vora P; Soriano-Gabarró M; Cheung KS; Leung WK; Wong ICK; Chan EW
BMJ Open; 2022 Feb; 12(2):e050510. PubMed ID: 35121597
[TBL] [Abstract][Full Text] [Related]
7. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
[TBL] [Abstract][Full Text] [Related]
8. Risk of hospitalization for upper gastrointestinal bleeding in Helicobacter pylori eradicated patients newly started on warfarin or direct oral anticoagulants: A population-based cohort study.
Jiang F; Ju C; Guo CG; Cheung KS; Li B; Law SYK; Lau WCY; Leung WK
Helicobacter; 2023 Aug; 28(4):e12990. PubMed ID: 37246782
[TBL] [Abstract][Full Text] [Related]
9. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
[TBL] [Abstract][Full Text] [Related]
10. Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users.
Chan FK; Ching JY; Suen BY; Tse YK; Wu JC; Sung JJ
Gastroenterology; 2013 Mar; 144(3):528-35. PubMed ID: 23333655
[TBL] [Abstract][Full Text] [Related]
11. Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long-term use of low-dose aspirin: A retrospective study of 612 509 patients.
Tsoi KK; Chan FC; Hirai HW; Sung JJ
J Gastroenterol Hepatol; 2018 Oct; 33(10):1728-1736. PubMed ID: 29665624
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study.
Luo PJ; Lin XH; Lin CC; Luo JC; Hu HY; Ting PH; Hou MC
J Formos Med Assoc; 2019 May; 118(5):939-944. PubMed ID: 30366771
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication: a population-based cohort study.
Jiang F; Guo CG; Cheung KS; Leung WK
Aliment Pharmacol Ther; 2021 Nov; 54(9):1162-1169. PubMed ID: 34528716
[TBL] [Abstract][Full Text] [Related]
14. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
[TBL] [Abstract][Full Text] [Related]
16. Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large Dutch cohorts.
de Groot NL; Hagenaars MP; Smeets HM; Steyerberg EW; Siersema PD; van Oijen MG
J Gastroenterol; 2014 Feb; 49(2):245-53. PubMed ID: 23609946
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin.
Lanas A; Fuentes J; Benito R; Serrano P; Bajador E; Sáinz R
Aliment Pharmacol Ther; 2002 Apr; 16(4):779-86. PubMed ID: 11929396
[TBL] [Abstract][Full Text] [Related]
18. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
19. Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study.
Bouget J; Balusson F; Viglino D; Roy PM; Lacut K; Pavageau L; Oger E
PLoS One; 2020; 15(8):e0237022. PubMed ID: 32764775
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study.
Fanning L; Wong ICK; Li X; Chan EW; Mongkhon P; Man KKC; Wei L; Leung WK; Darzins P; Bell JS; Ilomaki J; Lau WCY
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1550-1561. PubMed ID: 32936997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
